Prenatal phthalate exposure associated with autistic traits in young boys

February 19, 2020

Exposure in the womb to phthalates, a group of endocrine-disrupting chemicals present in cosmetics and other common household products, was associated with autistic traits in boys, ages 3 and 4, but not in girls, according to a new study led by a University of Massachusetts Amherst environmental epidemiologist.

Fewer of these autistic traits - which are characterized by social behavior, repetitive behaviors and restricted interests, but do not constitute an autism diagnosis - were found among boys whose mothers had taken the recommended dose of supplementary folic acid during their first trimester of pregnancy.

"This is one of the largest cohort studies about phthalates and neurodevelopment," says lead author Youssef Oulhote, assistant professor of biostatistics and epidemiology at UMass Amherst's School of Public Health and Health Sciences. "One of the most important findings is how adequate folic acid supplementation in pregnancy may offset the potential harmful effects of phthalates in regard to autistic traits."

Published Feb. 19 in the journal Environmental Health Perspectives, the study is the first to find this particular protective effect of folic acid supplements from phthalates. Oulhote adds that folic acid supplementation might also block the effects of other toxic chemicals, as already has been shown for pesticides and air pollutants.

While autism spectrum disorder "undoubtedly" has an underlying genetic basis, the study's findings strengthen the evidence that prenatal exposure to toxic chemicals contributes to the development of social impairment traits. Autism spectrum disorder affects about four times more males than females. The study examined only one point in the children's development.

"We do not know if these subtle effects associated with prenatal phthalate exposure will last after the preschool period," notes child development specialist and study co-author Gina Muckle, professor at Université Laval and Quebec-CHU Research Center in Quebec City, Canada.

Oulhote and colleagues in the U.S. and Canada analyzed data from the Maternal-Infant Research on Environmental Chemicals (MIREC) prospective cohort study, which enrolled 2,001 women during their first trimester of pregnancy from 10 cities in Canada between 2008 and 2011. Oulhote first worked on the MIREC study as a post-doctoral researcher and is still conducting additional analyses on other chemicals. So far, researchers have produced more than 70 papers in peer-reviewed scientific journals from examining MIREC's data sets.

For the current study, researchers measured 11 different phthalate metabolites in the pregnant women's urine samples taken during their first trimester and recorded the women's folic acid supplement intake. In follow-up investigation, 601 3- and 4-year-old children of the women underwent neuropsychological assessments, including the Social Responsiveness Scale-II (SRS-2) as a measure of autistic traits and social impairment. SRS-2 is a parent-reported questionnaire that has been found to be valid and reliable method to assess autistic traits in the general population and clinical settings. It correlates well with the assessment tools that physicians use to diagnose autistic spectrum disorder, although its validity in discriminating autism from other behavioral diagnoses deserves more attention, Oulhote says.

Increases in urinary concentrations of phthalate chemicals were associated with increases in SRS scores - but only among children whose mothers did not take an adequate folic acid supplement, 400 mcg daily, during their first trimester.

Oulhote notes that most of the women in the study were white, employed, married or living with a partner, and well-educated. "These are not the higher exposures for certain phthalates you will find in low-income communities," says Oulhote, explaining that cosmetics and other personal care products free of phthalates tend to be the most expensive and not affordable for low-income communities. Phthalates are also used in certain plastics, food packaging and medical devices.
-end-


University of Massachusetts Amherst

Related Autism Spectrum Disorder Articles from Brightsurf:

New genes related to autism spectrum disorder
The lack of some genes in the BEC/TCEAL cluster could be related to some alterations associated with the autism spectrum disorder, according to a preclinical study published in the journal Genome Biology, and led by Professor Jordi Garcia Fernàndez, from the Faculty of Biology and the Institute of Biomedicine of the University of Barcelona (IBUB), and researcher Jaime Carvajal, from the Andalusian Centre for Developmental Biology - University Pablo de Olavide (CSIC-UPO).

FABP4: Preschool-aged biomarker discovered for autism spectrum disorder
Researchers at the RIKEN Center for Brain Science in Japan have discovered a biomarker that can detect autism spectrum disorder (ASD) in preschool-aged children.

Autism spectrum disorder can be predicted from health checkups at 18 months
An early diagnosis of autism spectrum disorder, a type of developmental disorder was found to be effective from routine health checkups of infants at 18 months of age.

Alteration of calcium channel signaling may explain mechanism of autism spectrum disorder
Based on altering calcium channel kinetics and gene activation exhibited by the Timothy mutant, these results provide insight into the cellular mechanism that allows predicting disease risk, and genetic diagnosis of individuals with neurodevelopmental disorders.

Scientists uncover new genetic mutations linked to autism spectrum disorder
Scientists at Sanford Burnham Prebys Medical Discovery Institute and Radboud University Medical Center in the Netherlands have identified mutations in a gene called CNOT1 that affect brain development and impair memory and learning.

Unique metabolic markers detect over 50% of children affected by autism spectrum disorder
Blood sample analyses from the Children's Autism Metabolome Project have now reproducibly identified unique metabolic signatures in over 50% of the participating children with autism.

Genetic rescue of SHANK3 is potential therapy in rare forms of autism spectrum disorder
A mouse study by Craig Powell, M.D., Ph.D., and colleagues suggests that early genetic rescue may be a potential therapy in autism spectrum disorder, or ASD.

Investigation of inherited mutations in Autism Spectrum Disorder
Scientists from the Institute for Stem Cell Science and Regenerative Medicine (inStem) and collaborators investigated inherited mutations in Autism Spectrum Disorder.

Using virtual reality to help individuals with autism spectrum disorder
Novel interventions using virtual reality to aid individuals with autism spectrum disorder (ASD) handle common scenarios may include helping youngsters navigate air travel.

Studies of autism spectrum disorder reveal new avenues of neuroscience research
Advances in the study of cognitive disorders, including Autism Spectrum Disorder (ASD), may pave the way for future treatments.

Read More: Autism Spectrum Disorder News and Autism Spectrum Disorder Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.